Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B7346 PF 915275Summary: 11β-hydroxysteroid dehydrogenase type 1 (11βHSD1) inhibitor
-
B7356 PF 750Summary: FAAH inhibitor
-
B7402 Tris DBASummary: N-myristoyltransferase-1 (NMT-1) inhibitor
-
B7406 GSK 0660Summary: PPARδ antagonist
-
B7434 VU 0155069Summary: phospholipase D1 (PLD1) inhibitor
-
B7440 FIPISummary: phosholipase D (PLD) inhibitor
-
B7471 S26948Summary: PPARγ agonist
-
B7539 CDP 840 hydrochlorideSummary: PDE4 inhibitor,potent and selective
-
B7553 TesaglitazarSummary: Dual-specificity PPARα/γ agonist
-
B7599 Gisadenafil besylateSummary: PDE5 inhibitor